4.3 Article

Increased serum levels of soluble tumor necrosis factor-α receptor-1 in patients with Parkinson's disease

Journal

JOURNAL OF NEUROIMMUNOLOGY
Volume 216, Issue 1-2, Pages 122-125

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.jneuroim.2009.08.001

Keywords

Parkinson's disease; Inflammation; Tumor necrosis factor; Soluble tumor necrosis factor receptor

Funding

  1. Rede Instituto Brasileiro de Neurociencia (IBN Net/Finep)
  2. Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (Fapemig), Brazil

Ask authors/readers for more resources

Parkinson's disease (PD) is characterized by a progressive and irreversible loss of dopaminergic neurons. inflammatory mechanisms have been implied in the pathophysiology of PD. In this study, we assessed serum levels of TNF-alpha and the soluble forms of their receptors, sTNFR1 and sTNFR2, in 46 PD patients and 23 control subjects. Patients with PD had higher levels of sTNFR1 (p = 0.048). The concentration of sTNFR1 and sTNFR2 correlated with age (p = 0.006 and p = 0.022, respectively). Higher levels of sTNFR1 were associated with later disease onset (p = 0.048). These results corroborate the role of inflammatory events in the process of neurodegeneration in PD which can be of special relevance in the sporadic form of PD with later onset. (C) 2009 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available